Found: 9
Select item for more details and to access through your institution.
Gremlin1 promotes carcinogenesis of glioma in vitro.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 2, p. 244, doi. 10.1111/1440-1681.12697
- By:
- Publication type:
- Article
Risk factors of cerebrospinal fluid leakage after neuroendoscopic transsphenoidal pituitary adenoma resection: a systematic review and meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2023.1263308
- By:
- Publication type:
- Article
Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03131-7
- By:
- Publication type:
- Article
The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.718717
- By:
- Publication type:
- Article
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05667-4
- By:
- Publication type:
- Article
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1113, doi. 10.1093/neuonc/noac033
- By:
- Publication type:
- Article
CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4181, doi. 10.2147/OTT.S198762
- By:
- Publication type:
- Article
Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.581197
- By:
- Publication type:
- Article
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 1129, doi. 10.2147/OTT.S237162
- By:
- Publication type:
- Article